| Whole genome sequencing reveals host factors underlying critical Covid-19 A Kousathanas, E Pairo-Castineira, K Rawlik, A Stuckey, CA Odhams, ... Nature, 1-10, 2022 | 223 | 2022 |
| SARS-CoV-2 antibody seroprevalence in the general population and high-risk occupational groups across 18 cities in Iran: a population-based cross-sectional study H Poustchi, M Darvishian, Z Mohammadi, A Shayanrad, A Delavari, ... The Lancet Infectious Diseases 21 (4), 473-481, 2021 | 175 | 2021 |
| A first update on mapping the human genetic architecture of COVID-19 Writing group lead Andrews Shea J. 6 Kanai Masahiro 3 Cordioli Mattia 7, ... Nature 608 (7921), E1-E10, 2022 | 153* | 2022 |
| Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence S Moody, S Senkin, SM Islam, J Wang, D Nasrollahzadeh, ... Nature Genetics 53 (11), 1553-1563, 2021 | 82 | 2021 |
| APOBEC3A Is Implicated in a Novel Class of G-to-A mRNA Editing in WT1 Transcripts A Niavarani, E Currie, Y Reyal, F Anjos-Afonso, S Horswell, E Griessinger, ... PloS one 10 (3), e0120089, 2015 | 60 | 2015 |
| SARS-CoV-2 susceptibility and COVID-19 disease severity are associated with genetic variants affecting gene expression in a variety of tissues M D’Antonio, JP Nguyen, TD Arthur, H Matsui, BM Neale, M Daly, ... Cell reports 37 (7), 2021 | 27 | 2021 |
| Pancancer Analysis Identifies Prognostic High-APOBEC1 Expression Level Implicated in Cancer In-Frame Insertions and Deletions A Niavarani, A Shahrabi Farahani, M Sharafkhah, M Rassoulzadegan Carcinogenesis, 2018 | 20 | 2018 |
| A 4‐gene expression score associated with high levels of Wilms Tumor‐1 (WT1) expression is an adverse prognostic factor in acute myeloid leukaemia A Niavarani, T Herold, Y Reyal, MC Sauerland, T Buchner, W Hiddemann, ... British journal of haematology 172 (3), 401-411, 2016 | 19 | 2016 |
| A novel single step double positive double negative selection strategy for β-globin gene replacement H Khanahmad, MRN Daloii, MA Shokrgozar, K Azadmanesh, ... Biochemical and biophysical research communications 345 (1), 14-20, 2006 | 17 | 2006 |
| Development of transgenic mice expressing calcitonin as a beta-lactoglobulin fusion protein in mammary gland A Niavarani, S Dehghanizadeh, S Zeinali, M Karimi, M Magliano, ... Transgenic research 14, 719-727, 2005 | 15 | 2005 |
| Genome-wide association study of long COVID V Lammi, T Nakanishi, SE Jones, SJ Andrews, J Karjalainen, B Cortés, ... medRxiv, 2023.06. 29.23292056, 2023 | 11 | 2023 |
| Molecular dynamics analysis predicts ritonavir and naloxegol strongly block the SARS-CoV-2 spike protein-hACE2 binding M Bagheri, A Niavarani Journal of Biomolecular Structure and Dynamics 40 (4), 1597-1606, 2022 | 11 | 2022 |
| The Wilms Tumor-1 (WT1) rs2234593 variant is a prognostic factor in normal karyotype acute myeloid leukemia A Niavarani, S Horswell, R Sadri, D Bonnet Annals of hematology 95, 179-190, 2016 | 11 | 2016 |
| Seroprevalence of SARS-CoV-2 antibody among urban Iranian population: findings from the second large population-based cross-sectional study M Zamani, H Poustchi, Z Mohammadi, S Dalvand, M Sharafkhah, ... BMC public health 22 (1), 1031, 2022 | 9 | 2022 |
| Dynamics of the COVID-19 Clinical Findings and the Serologic Response A Niavarani, H Poustchi, A Shayanrad, M Sharafkhah, Z Mohammadi, ... Frontiers in microbiology, 2944, 2021 | 2 | 2021 |
| A Novel Single Step Double Positive Double Negative Selection Strategy For Β-Globin Gene Replacement HK Ahmad, N Daloie, KA Moghaddam, MA Shokrgozar, K Azadmanesh, ... Cell Journal (Yakhteh) 8 (2), 98-105, 2006 | 2 | 2006 |
| The long-term outcome and efficacy of PR1/BCR-ABL multipeptides vaccination in chronic myeloid leukemia: results of a 7-year longitudinal investigation SH Ghaffari, E Osfouri, M Ahmadvand, D Bashash, P Ghaffari, A Niavarani, ... Iranian Journal of Blood and Cancer 14 (4), 84-94, 2022 | | 2022 |
| APOBEC/ADAR aberrations are potentially implicated in certain pancancer hypermutation patterns A Niavarani, M Bagheri, JCF Ng, F Fraternali, R Malekzadeh Cancer Research 80 (16_Supplement), 1318-1318, 2020 | | 2020 |
| Distinct pancancer mutational signatures are determined by APOBEC/ADAR aberrations A Niavarani, AS Farahani, M Sharafkhah, LB Alexandrov, R Malekzadeh Cancer Research 80 (16_Supplement), 1319-1319, 2020 | | 2020 |
| A 16-Gene Signature Associated with High Levels of Wilms Tumor-1 (WT1) Expression Is an Adverse Prognostic Factor in Acute Myeloid Leukemia A Niavarani, T Herold, Y Reyal, E Currie, S Horswell, A Jalali, ... Blood 124 (21), 1021, 2014 | | 2014 |
Reza Malekzadeh M.DProfessor of Internal Medicine ,&Gastroenterology Tehran University of Medical Sciences, IranVerified email at tums.ac.ir
